Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 3:05 pm Purchase | 2023-12-31 | 13G | PRAXIS PRECISION MEDICINES INC PRAX | Cormorant Asset Management, LP | 633,345 7.390% | 633,345 (New Position) | Filing History |
| 2024-02-14 3:04 pm Purchase | 2023-12-31 | 13G | TARSUS PHARMACEUTICALS INC TARS | Cormorant Asset Management, LP | 2,221,422 6.710% | 485,000 (+27.93%) | Filing History |
| 2024-02-14 3:04 pm Purchase | 2023-12-31 | 13G | LONGBOARD PHARMACEUTICALS INC LBPH | Cormorant Asset Management, LP | 2,141,506 9.990% | 339,559 (+18.84%) | Filing History |
| 2024-02-14 3:03 pm Sale | 2023-12-31 | 13G | KORRO BIO INC KRRO | Cormorant Asset Management, LP | 529,170 6.610% | -150,000 (-22.09%) | Filing History |
| 2024-02-14 3:03 pm Purchase | 2023-12-31 | 13G | AMBRX BIOPHARMA INC AMAM | Cormorant Asset Management, LP | 11,231,000 17.780% | 11,231,000 (New Position) | Filing History |
| 2024-02-14 3:02 pm Sale | 2023-12-31 | 13G | MONTE ROSA THERAPEUTICS INC CO GLUE | Cormorant Asset Management, LP | 0 0.000% | -2,893,717 (Position Closed) | Filing History |
| 2024-02-14 3:02 pm Sale | 2023-12-31 | 13G | ELEVATION ONCOLOGY INC ELEV | Cormorant Asset Management, LP | 0 0.000% | -1,952,032 (Position Closed) | Filing History |
| 2024-02-14 3:01 pm Sale | 2023-12-31 | 13G | ELEDON PHARMACEUTICALS INC ELDN | Cormorant Asset Management, LP | 0 0.000% | -1,391,663 (Position Closed) | Filing History |
| 2024-02-14 3:01 pm Sale | 2023-12-31 | 13G | CONSTELLATION PHARMACEUTICALS CNST | Cormorant Asset Management, LP | 0 0.000% | -5,150,000 (Position Closed) | Filing History |
| 2024-02-14 3:01 pm Sale | 2023-12-31 | 13G | CABALETTA BIO INC CABA | Cormorant Asset Management, LP | 0 0.000% | -1,971,739 (Position Closed) | Filing History |
| 2024-02-14 3:00 pm Sale | 2023-12-31 | 13G | ASTRIA THERAPEUTICS INC ATXS | Cormorant Asset Management, LP | 0 0.000% | -1,650,000 (Position Closed) | Filing History |
| 2024-02-14 3:00 pm Sale | 2023-12-19 | 13G | 89BIO INC ETNB | Cormorant Asset Management, LP | 0 0.000% | -2,550,000 (Position Closed) | Filing History |
| 2024-01-30 4:41 pm Sale | 2023-11-29 | 13D | ERASCA INC ERAS | Cormorant Asset Management, LP | 0 0.000% | -10,893,107 (Position Closed) | Filing History |
| 2023-12-14 4:04 pm Purchase | 2023-12-04 | 13G | EYEPOINT INC EYPT | Cormorant Asset Management, LP | 6,038,235 12.360% | 6,038,235 (New Position) | Filing History |
| 2023-11-16 4:02 pm Purchase | 2023-11-06 | 13G | KORRO BIO INC KRRO | Cormorant Asset Management, LP | 679,170 8.490% | 679,170 (New Position) | Filing History |
| 2023-11-13 4:03 pm Purchase | 2023-11-01 | 13G | VYNE THERAPEUTICS INC VYNE | Cormorant Asset Management, LP | 27,887 9.990% | 27,887 (New Position) | Filing History |
| 2023-11-06 4:01 pm Purchase | 2023-10-25 | 13G | HARPOON THERAPEUTICS INC HARP | Cormorant Asset Management, LP | 1,678,619 9.900% | 1,678,619 (New Position) | Filing History |
| 2023-10-23 4:02 pm Purchase | 2023-10-11 | 13G | ALPINE IMMUNE SCIENCES INC ALPN | Cormorant Asset Management, LP | 2,850,000 5.790% | 2,850,000 (New Position) | Filing History |
| 2023-10-13 4:00 pm Purchase | 2023-10-03 | 13G | ALX ONCOLOGY HLDGS INC ALXO | Cormorant Asset Management, LP | 3,142,079 6.310% | 3,142,079 (New Position) | Filing History |
| 2023-10-10 4:01 pm Purchase | 2023-09-29 | 13G | MARINUS PHARMACEUTICALS INC MRNS | Cormorant Asset Management, LP | 2,800,000 5.530% | 2,800,000 (New Position) | Filing History |